Inhibitory Activity of Cinnamon Bark Oil on Group B Streptococci (GBS)

References

• Adams, R.P. (2007). Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy. fourth ed. Allured Publishing Corporation. Carol Stream, Illinois, USA.
   Google Scholar
• Barcaite, E., Bartusevicius, A., Tameliene, R., Kliucinskas, M., Maleckiene, L. and Nadisauskiene, R. (2008). Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstet. Gynecol. Scand. 87: 260–271.
   PubMed Web of Science ®Google Scholar
• Ben-Yehoshua, S. (2008). Microbiocidal formulation comprising essential oils or their derivatives. US20087465469.
   Google Scholar
• Bohnsack, J.F., Whiting, A.A., Bradford, R.D., Van Frank, B.K., Takahashi, S. and Adderson, E.E. (2000). Genetic polymorphisms of group B Streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a. Infect. Immun. 68: 5018–5025. doi: 10.1128/IAI.68.9.5018-5025.2000
   PubMed Web of Science ®Google Scholar
• Borchardt, S.M., DeBusscher, J.H., Tallman, P.A., Manning, S.D., Marrs, C.F., Kurzynski, T.A. and Foxman, B. (2006). Frequency of antimi-crobial resistance among invasive and colonizing group B streptococcal isolates. BMC Infect. Dis. 6: 57–64. doi: 10.1186/1471-2334-6-57
   PubMed Web of Science ®Google Scholar
• Bouhdid, S., Abrini, J., Amensour, M., Zhiri, A., Espuny, M.J. and Manresa, A. (2010). Functional and ultrastructural changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Cinnamomum verum essential oil. J. Appl. Microbiol. 109: 1139–1149.
   Google Scholar
• Brown, C.K., Gu, Z.Y., Matsuka, Y.V., Purushothaman, S.S., Winter, L.A., Cleary, P.P., Olmsted, S.B., Ohlendorf, D.H. and Earhart, C.A. (2005). Structure of the streptococcal cell wall C5a peptidase. PNAS. 102: 18391–18396. doi: 10.1073/pnas.0504954102
   PubMed Web of Science ®Google Scholar
• Carlin, A.F., Lewis, A.L., Varki, A. and Nizet, V. (2007). Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes. J. Bacteriol. 189: 1231–1237. doi: 10.1128/JB.01155-06
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC): 2003-2005. (2007). Perinatal group B streptococcal disease after universal screening recommendations - United States, MMWR Morb. Mortal. Wkly. Rep. 56: 701–705.
   Google Scholar
• Centers for Disease Control and Prevention (CDC): 2000-2006. (2009). Trends in perinatal group B streptococcal disease – United States, MMWR Morb. Mortal. Wkly. Rep. 58: 109–112.
   Google Scholar
• Chaudhry, N.M.A. and Tariq, P. (2006). Anti-microbial activity of Cinnamomum cassia against diverse microbial flora with its nutritional and medicinal impacts. Pak. J. Bot. 38: 169–174.
   Web of Science ®Google Scholar
• Dahesh, S., Hensler, M.E., Van Sorge, N.M., Gertz, R.E.Jr., Schrag, S., Nizet, V. and Beall, B.W. (2008). Point mutation in the group B streptococcal pbp2x gene conferring decreased suscep-tibility to beta-lactam antibiotics. Antimicrob. Agents Chemother. 52: 2915–2918. doi: 10.1128/AAC.00461-08
   PubMed Web of Science ®Google Scholar
• Dechen, T.C., Sumit, K. and Ranabir, P. (2010). Correlates of vaginal colonization with group B streptococci among pregnant women. J. Glob. Infect. Dis. 2: 236–241.
   Google Scholar
• Doran, K.S., Engelson, E.J., Khosravi, A., Maisey, H.C., Fedtke, I., Equils, O., Michelsen, K.S., Arditi, M., Peschel, A. and Nizet, V. (2005). Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J. Clin. Invest. 115: 2499–2507.
   Google Scholar
• Edwards, M.S. and Baker, C.J. (2005). Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 41: 839–847.
   Google Scholar
• European Committee on Antimicrobial Susceptibility Testing (EUCAST). (2012). Breakpoint Tables for Interpretation of MICs and Zone Diameters, version 2.0; valid from 1 January 2012; Available online: www.eucast.org (accessed on 16 December 2012).
   Google Scholar
• European Pharmacopeia. (2008). 6th ed., Council of Europe, Strasbourg.
   Google Scholar
• Fani, M.M. and Kohanteb, J. (2011). Inhibitory activity of Cinnamon zeylanicum and Eucalyptus globulus oils on Streptococcus mutans, Staphylococcus aureus, and Candida species isolated from patients with oral infections. Shiraz Univ. Dent. J. 11: 14–22.
   Google Scholar
• Fluegge, K., Supper, S., Siedler, A. and Berner, R. (2005). Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany. Clin. Infect. Dis. 40: 760–763.
   Google Scholar
• Friedman, M., Henika, P.R. and Mandrell, R.E. (2002). Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica. J. Food Prot. 65: 1545–1560.
   PubMed Web of Science ®Google Scholar
• Garland, S.M., Cottrill, E., Markowski, L., Pearce, C., Clifford, V., Ndisang, D., Kelly, N. and Daley, A. (2011). Agar Gbs Resistance Study Group FT: Antimicrobial resistance in group B Streptococcus: the Australian experience. J. Med. Microbiol. 60: 230–235.
   PubMed Web of Science ®Google Scholar
• Gruenwald, J., Freder, J. and Armbruester, N. (2010). Cinnamon and health. Crit. Rev. Food Sci. Nutr. 50: 822–834.
   Google Scholar
• Gygax, S.E., Schuyler, J.A., Kimmel, L.E., Trama, J.P., Mordechai, E. and Adelson, M.E. (2006). Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrob. Agents Chemother. 50: 1875–1877. doi: 10.1128/AAC.50.5.1875-1877.2006
   PubMed Web of Science ®Google Scholar
• Heath, P.T. and Schuchat, A. (2007). Perinatal group B streptococcal disease. Best Pract. Res. Clin. Obstet. Gynaecol. 21: 411–424. doi: 10.1016/j.bpobgyn.2007.01.003
   PubMed Web of Science ®Google Scholar
• Hensler, M.E., Liu, G.Y., Sobczak, S., Benirschke, K., Nizet, V. and Heldt, G.P. (2005). Virulence role of group B Streptococcus beta-hemolysin/cytolysin in a neonatal rabbit model of early-onset pulmonary infection. J. Infect. Dis. 191: 1287–1291. doi: 10.1086/428946
   PubMed Web of Science ®Google Scholar
• Inouye, S., Takizawa, T. and Yamaguchi, H. (2001). Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. J. Antimicrob. Chemother. 47: 565–573. doi: 10.1093/jac/47.5.565
   PubMed Web of Science ®Google Scholar
• Inouye, S., Yamaguchi, H. and Takizawa, T. (2001). Screening of the antibacterial effects of a variety of essential oils on respiratory tract pathogens, using a modified dilution assay method. J. Infect. Chemother. 7: 251–254. doi: 10.1007/s101560170022
   PubMedGoogle Scholar
• Jahromi, B.N., Poorarian, S. and Poorbarfehee, S. (2008). The prevalence and adverse effects of group B streptococcal colonization during pregnancy. Arch. Iranian Med. 11: 654–657.
   Google Scholar
• Joulain, D. and König, W.A. (1998). The Atlas of Spectral Data of Sesquiterpene Hydrocarbons. E.B.-Verlag, Hamburg.
   Google Scholar
• Kimura, K., Suzuki, S., Wachino, J.I., Kurokawa, H., Yamane, K., Shibata, N., Nagano, N., Kato, H., Shibayama, K. and Arakawa, Y. (2008). First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 52: 2890–2897.
   Google Scholar
• Kobayashi, A., Okamoto, H. and Okada, F. (2008). Antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same. US20087384646.
   Google Scholar
• Kobayashi, A., Okamoto, H. and Okada, F. (2010). Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides. US20107754774.
   Google Scholar
• Lancefield, R.C. (1934). A serological differentiation of specific types of bovine hemolytic streptococci (group B). J. Exp. Med. 59: 441–58. doi: 10.1084/jem.59.4.441
   PubMedGoogle Scholar
• Leclair, C.M., Hart, A.E., Goetsch, M.F., Carpentier, H. and Jensen, J.T. (2010). Group B streptococcus: prevalence in a non-obstetric population. J Low Genit Tract Dis. 14: 162–166.
   Google Scholar
• Lopez, P., Sanchez, C., Batlle, R. and Ner´ýn, C. (2007). Vapor-phase activities of cinnamon, thyme, and oregano essential oils and key constituents against foodborne microorganisms. J. Agric. Food Chem. 55: 4348–4356.
   Google Scholar
• Lopez, P., Sanchez, C., Batlle, R. and Nerýn, C. (2005). Solid- and vapor-phase antimicrobial activities of six essential oils: susceptibility of selected foodborne bacterial and fungal strains. J. Agric. Food Chem. 53: 6939–6946.
   Google Scholar
• Luck, S., Torny, M., d'Agapeyeff, K., Pitt, A., Heath, P., Breathnach, A. and Russell, A.B. (2003). Estimated early-onset group B streptococcal neonatal disease. Lancet. 361:1953–1954. doi: 10.1016/S0140-6736(03)13553-2
   PubMed Web of Science ®Google Scholar
• Manning, S.D., Neighbors, K., Tallman, P.A., Gillespie, B., Marrs, C.F., Borchardt, S.M., Baker, C.J., Pearlman, M.D. and Foxman, B. (2004). Prevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women. Clin. Infect. Dis. 39: 380–388. doi: 10.1086/422321
   PubMed Web of Science ®Google Scholar
• Mavenyengwa, R.T., Maeland, J.A. and Moyo, S.R. (2009). Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B Streptococcus from Zimbabwe. Clin. Vaccine Immunol. 16: 1302–1308.
   PubMed Web of Science ®Google Scholar
• Mayaud, L., Carricajo, A., Zhiri, A. and Aubert, G. (2008). Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics. Lett. Appl. Microbiol. 47: 167–173. doi: 10.1111/j.1472-765X.2008.02406.x
   PubMed Web of Science ®Google Scholar
• Nagano, N., Nagano, Y., Kimura, K., Tamai, K., Yanagisawa, H. and Arakawa, Y. (2008). Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 52: 4258–4267.
   Google Scholar
• Panda, B., Iruretagoyena, I., Stiller, R. and Panda, A. (2009). Antibiotic resistance and penicillin tolerance in ano-vaginal group B streptococci. J. Matern. Fetal Neonatal. Med. 22: 111–114. doi: 10.1080/14767050802488212
   PubMed Web of Science ®Google Scholar
• Persson, E., Berg, S., Bergseng, H., Bergh, K., Valsö-Lyng, R. and Trollfors, B. (2008). Antimicrobial susceptibility of invasive group B streptococcal isolates from south-west Sweden 1988–2001. Scand. J. Infect. Dis. 40: 308–313. doi: 10.1080/00365540701678702
   PubMed Web of Science ®Google Scholar
• Pettersson, K.S. (2007). Perinatal infection with group B streptococci. J. Matern. Fetal. Neonata.l Med. 12: 193–197. doi: 10.1016/j.siny.2007.01.010
   Web of Science ®Google Scholar
• Picard, F.J. and Bergeron, M.G. (2004). Laboratory detection of group B Streptococcus for prevention of perinatal disease. Eur. J. Clin. Microbiol. Infect. Dis. 23: 665–671. doi: 10.1007/s10096-004-1183-8
   PubMed Web of Science ®Google Scholar
• Polish Pharmacopeia VIII. (2008). 8 th ed, Polish Pharmaceutical Society, Warsaw.
   Google Scholar
• Pritchard, D.G., Trent, J.O., Li, X., Zhang, P., Egan, M.L. and Baker, J.R. (2000). Characterization of the active site of group B streptococcal hyaluronan lyase. Proteins. 40: 126–134.
   Google Scholar
• Rattanachaikunsopon, P. and Phumkhachorn, P. (2010). Potential of cinnamon (Cinnamomum verum) oil to control Streptococcus iniae infection in tilapia (Oreochromis niloticus). Fish Sci. 76: 287–293.
   Google Scholar
• Schoening, T.E., Wagner, J. and Arvand, M. (2005). Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany. Clin. Microbiol. Infect. 11: 579–582. doi: 10.1111/j.1469-0691.2005.01180.x
   PubMed Web of Science ®Google Scholar
• Schrag, S., Gorwitz, R., Fultz-Butts, K. and Schuchat A. (2002). Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm. Rep. 51: 1–22.
   PubMedGoogle Scholar
• Shahverdi, A.R., Monsef-Esfahani, H.R., Tavasoli, F., Zaheri, A. and Mirjani R. (2007). Trans-cinnamaldehyde from Cinnamomum zeylanicum bark essential oil reduces the clindamycin resistance of Clostridium difficile in vitro. J. Food Sci.72: S055–8. doi: 10.1111/j.1750-3841.2006.00204.x
   PubMed Web of Science ®Google Scholar
• Sivamani, P. and Sahul Hameed, A.S. (2010). In vitro antibacterial activity of essential oils of selected herbals against isolates from HIV/AIDS patients. J. Pharm. Res. 3: 672–678.
   Google Scholar
• Skoff, T.H., Farley, M.M., Petit, S., Craig, A.S., Schaffner, W., Gershman, K., Harrison, L.H., Lynfield, R. and Schrag, S.J. (2009). Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007. CID. 49: 85–92. doi: 10.1086/599369
   PubMed Web of Science ®Google Scholar
• Spellerberg, B. (2000). Pathogenesis of neonatal Streptococcus agalactiae infections. Microbes. Infect. 14: 1733–1742. doi: 10.1016/S1286-4579(00)01328-9
   Web of Science ®Google Scholar
• Verani, J.R., McGee, L. and Schrag, S.J. (2010). Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC): Prevention of perinatal group B streptococcal disease - revised guidelines from CDC. 2010. MMWR Recomm. Rep. 59: 1–36.
   PubMedGoogle Scholar
• Zhu, Z.P., Zhang, M.F., Shen, Y. and Chen, G.J. (1993). Pharmacological study on spleen- stomach warming and analgesic action of Cinnamomum cassia Presl. Zhongguo Zhong. Yao Za Zhi. 18: 553–555.
   PubMedGoogle Scholar